Clinical trials: Retained Foreign Object
Intraocular Foreign Body
Extraction Routes of Intraocular Foreign Body
Intra ocular foreign body removal is indicated to avoid further many complications such as retinal detachment, endophthalmitis. The surgical approach for a posterior segment IOFB is pars plana vitrectomy and its extraction either…
- Trial name
- IOFB (NCT05966545)
- Testing
- pars plana vitrectomy and intraocular foreign body removal
- Where
- Egypt
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Zagazig University
Retained Surgical Items
Prevention of Retained Items iN Childbirth Environment and Surgical Sites
To evaluate the user confidence in the confirmation of correct counts using a novel device and to assess clinical usability of the device during surgery.
- Trial name
- PRINCESS (NCT06570304)
- Testing
- iCount Device
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
Surgical Complication Nec
Effectiveness of a RF Sponge Detection
Retained surgical items (e.g. sponges, needles, and instruments) remain the most frequently reported serious adverse event for five of the last six years.
- Trial name
- NCT02837224
- Testing
- The Situate Detection System
- Volunteers
- 27,637 people, healthy volunteers welcome
- Sponsor
- University of Iowa
Surgical Item, Retained, Childbirth
Feasibility Study to Evaluate the Role of a Novel Device in Childbirth
Accidentally retained surgical items or swabs are well-recognised errors that result in adverse consequences for patients. This error is one of the commonest "Never Events" - patient safety incidents that are considered…
- Trial name
- PRINCE (NCT05373342)
- Testing
- iCount system assembled with swabs
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
Breast Cancer, Surgery
Evaluation of ADM Soft Tissue Reinforcement
The use of acellular dermal matrix (ADM) has facilitated implant-based breast reconstruction, both in single-stage direct-to-implant (DTI) and staged tissue expander placement.
- Conditions
- Breast Cancer, Surgery, Surgical Item, Retained
- Trial name
- NCT03494244
- Testing
- Direct-to-implant breast reconstruction, Acellular dermal matrix
- Volunteers
- 152 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital